KAREN SACKS: Open Payments
NPI 1679108732 · IMPERIAL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 14 payments from 6 companies in 2025. Trend: 2023 $1,328 · 2024 $193 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $78 |
| Lilly USA, LLC | 4 | $70 |
| Novo Nordisk Inc | 2 | $49 |
| Dexcom, Inc. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: MOUNJARO, TRELEGY ELLIPTA, Ozempic, Dexcom G6 Transmitter, SHINGRIX, XIFAXAN, VOQUEZNA.
Industry payments across PA — which companies pay providers there.
